Keywords: Bayer, Stivarga, Advanced GIST, USA, FDA, Onyx Pharma

FDA expands use of Bayer and Onyx' Stivarga for advanced GIST

Article | 26 February 2013

Print This

The US Food and Drug Administration yesterday expanded the approved use of German drug major Bayer’s (BAYN: DE) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in